According to Swedish Orphan Biovitrum's latest financial reports the company's total assets are NZ$11.72 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | NZ$12.13 B | 4.4% |
2023-12-31 | NZ$11.62 B | 46.18% |
2022-12-31 | NZ$7.95 B | 0.98% |
2021-12-31 | NZ$7.87 B | -3.63% |
2020-12-31 | NZ$8.17 B | 12.64% |
2019-12-31 | NZ$7.25 B | 154.32% |
2018-12-31 | NZ$2.85 B | 52% |
2017-12-31 | NZ$1.87 B | 18.37% |
2016-12-31 | NZ$1.58 B | 9.75% |
2015-12-31 | NZ$1.44 B | 37.74% |
2014-12-31 | NZ$1.04 B | -15.24% |
2013-12-31 | NZ$1.23 B | 4.94% |
2012-12-31 | NZ$1.17 B | -5.54% |
2011-12-31 | NZ$1.24 B | -8.08% |
2010-12-31 | NZ$1.35 B | 148.86% |
2009-12-31 | NZ$0.54 B | -3.84% |
2008-12-31 | NZ$0.56 B | 44.11% |
2007-12-31 | NZ$0.39 B | -8.64% |
2006-12-31 | NZ$0.43 B | -14.03% |
2005-12-31 | NZ$0.50 B | -1.01% |
2004-12-31 | NZ$0.50 B | -0.08% |
2003-12-31 | NZ$0.50 B | 15.73% |
2002-12-31 | NZ$0.43 B |